Member Info for MIKODX

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to what action you should take, you are recommended to seek your own financial advice from your stockbroker, solicitor, accountant or other independent adviser authorised under the Financial Services and Markets Act 2000 immediately.

If you have sold or otherwise transferred all of your shares in Cineworld Group plc, please forward this document as soon as possible to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was arranged for transmission to the purchaser or transferee.

Dear Shareholder
General Meeting
A General Meeting of Cineworld Group plc (the “Company”) will be held on 20 April 2023 at 10:00 a.m. at Vantage London, Great West Road, Brentford, England TW8 9AG (the “General Meeting”) pursuant to section 656 of the Companies Act 2006 (the “Act”). The notice of meeting is set out on page 2 (the “Notice of Meeting”). Details of the item of business to be proposed at the meeting are set out below.

Section 656 of the Act – serious loss of capital
In circumstances where the value of the Company’s net assets is less than half of its called-up share capital (constituting a “serious loss of capital” under the Act), its Directors are required, pursuant to section 656 of the Act, to convene a general meeting of the Company for the purpose of allowing shareholders to consider whether any, and, if so, what, steps should be taken to deal with the situation. Accordingly, the Board is calling the General Meeting to ensure that this matter is addressed as required by the Act. The Board welcomes dialogue with the Company’s shareholders, and the General Meeting will provide a forum for such discussions to take place, but no resolutions will be proposed at the General Meeting.

The Company remains in discussions with its key stakeholders with a view to developing a Chapter 11 plan of reorganisation that maximises value for the benefit of the Group and its stakeholders. The marketing process, which was announced on 3 January 2023, is continuing in parallel. As previously announced, it is not expected that any plan of reorganisation or sale transaction would result in any recovery for the Company’s shareholders. Further updates will be provided to shareholders by way of announcement when appropriate and will be made available on the Company’s website at www.cineworldplc.com.

The Board does not consider it necessary to propose a specific resolution in relation to the serious loss of capital and shareholders will not be asked to vote at the General Meeting. Instead, the Board invites shareholders of the Company to discuss the serious loss of capital and to put questions to the Board.

I'm not saying there will be a takeover, I'm saying they will be issuing new shares under the new arrangement. So wouldn't they need to change the company name to issue new shares? Surely they couldn't issue new shares under the current name as this is owned or partly owned by current shareholders. Shareholders are part owners of the stock, surely they cant just freeze us out like that without our consent. 1 share means 1 vote last time I looked.

Well, to issue new shares they would first have to suspend or cancel the current shares. This will be done when the company restructuring arrangements have been passed by the judge. However, doesn't the restructuring arrangements have to be passed by current shareholders first or don't we have a say? I'll be definitely voting against this if we do. Not giving up my shares without a fight, they will have to find some other way that includes or compensates shareholders.

I got into GDR in Jan 2020. I bought and sold on the highs and lows and was doing okay to begin with. Then I stupidly got carried away with the POC test and bought in at 150. I've managed to average down to 50 now but I've learnt some valuable lessons on the way. One I mentioned earlier was never buy penny stocks for pounds. No matter how much you think the company has a product that will come to market, there's always the possibility that things could go wrong. That's exactly what happened to GDR and the POC test. AIHL coming to market now, just might be the start of a recovery for LT holders.

starresnstoff - If you got in at 9p you must be sitting on very healthy profits.

forest79 - I'm with you on that one. Lets get something started on Redditt.

When you start adding up the amount of scope in the UK alone, the AIHL has a decent market. To supply all/most hospitals with the Genedrive machine would generate £10M for the company. Add the tests to that your looking at another £20M, that's a £30M market for the AIHL alone. Also the amount of companies and organisations that have a stake in this product is huge. the stakeholder list can be viewed here.

https://www.nice.org.uk/guidance/hte6/documents/stakeholder-list

My guess is after it has been rolled out to the outstanding Manchester sites, it will be used for a few months where more data will be collected. Once the data collection is complete it will then be rolled out very quickly throughout the rest of the country. Wont be long before GDR has a good stream of income and it could happen within the year.

Lol, if you bought in Feb/March 2020, then you would have o have had a lot of patience. This year could be the year that we reach those numbers again. Anyway if you bought in at those numbers in 2020 then you only have yourself to blame. GDR is what you call a penny stock. If you bought it for pounds then your taking a huge risk. Thats the whole point of penny stocks, you buy for pennies and sell for pounds, not the other way round. A harsh lesson and one you and anyone else who bought back then, should learn from.

stephen11 - lol there are a lot more than 7 private hospitals in the U.K. Add two zeroes on the end of that you’ll be closer to the right figure.

"Disappointment over the progress of AIHL?"

Just no pleasing some people, AIHL is progressing along just fine. Were expanding to five hospitals in Manchester and I'm sure very soon we will be expanding even more. If we will be supplying private Hospitals as well then that just means more revenue for GDR.

Thought I’d change the title from the previous one thats been doing the rounds and is totally incorrect. The company has clearly stated on numerous occasions that Cineworld will continue to trade on the market and that the company has no plans to sell off the business. Don’t understand why the knuckleheads continue to say otherwise.

We need another public announcement about the success of the test and the plans to expand it across more hospitals. This will get the SP moving up and attract more investors.

That should be £5M in income stream not £5 lol.

You see, the bankrupt company has to be seen to be giving investors ample warning that there shares will be possibly wiped out after the restructuring. Thats there way of covering their own backs against any future lawsuits. That doesn't mean to say that's what is going to happen, they may well looking into what can be offered to shareholders under the new structure. All one can do now is get out and take a huge loss or hold and pray.

The truth is no one really knows how much GDR will get after everyone else gets their cut from the tests. My guess is the UK market will generate around £5 in income stream, A relatively small market when you take into account the product that is being offered, but a potentially huge one if taken up by other countries.

roger65 - It's £80 without the tax, around £1.10 including the tax, get it now?

The best shareholders can hope for and I for one will be happy with, is 10:1 split of the new shares with the new shares costing around a pound. I know that's wishful thinking but it is a possibility according to the draft deal found here.

https://www.cineworldplc.com/sites/cineworld-plc/files/investors/draft-proposed-cleansing-package-deal-company-draft-4-2-2023-95026939-1.pdf

The AIHL test is a very cheap test which is why I think eventually the test will be used in the whole UK. The five NHS Manchester Hospitals that have adopted the test you can do the maths. Budd says the five Hospitals will bring in 30,000 tests on avareage. Each machine will cost £5,00£0 and I assume there will be one at every site, so five machines will be £25,000. 30,000 tests at roughly £1.10 is £33,000 plus £25,000 is 58,000, not enought to run the lights. We will have to cover a lot more areas than Manchester to generate any serious sales.

As I said earlier, because the test is so cheap and cost eefective I think it will be rolled out to the whole of the UK. The real money will come from initial sales of the Genedrive machine itself. There are roughly 1300 Hospitals in the UK, sales of the Genedrive in all these locations would generate around £7M, cheap enough for the test to be rolled out countrywide and a decent stream of income for GDR. I agree though, it will be a gradual process. Lets just hope that bureacracy within the NHS prevents this from happening. So far we have a start in Manchester.

roger65 - You are so full of contradiction and dont make any sense at all. On one hand you complain about the derampers trying to downplay the company, then turn around and do the very same thing. You say Riverfort are circling GDR like vultures and that they can bring GDR to their knees at anytime. That's utter rubbish. What makes you think Riverfort are trying to buy out GDR and what makes you think they now have major control on how GDR conducts their affairs?

Riverfort Global are a funding company basically money lenders, they have no interest in buying out GDR. This is simply an investment for them. They see GDR on the verge of doing big things and they want to invest in it. Riverfort couldn't buy out your local toilets if they wanted to, GDR are a far bigger company than them, and that's saying something. I wish you would get your facts right before opening your mouth and spewing a lot of inaccurate misinformation.

We're talking about the Placing price, not when we got spiked two weeks ago.